177 related articles for article (PubMed ID: 12901128)
21. Catheter-related thrombosis in hematologic patients.
Moia M; Cortelezzi A; Falanga A
Rev Clin Exp Hematol; 2004 Jun; 8(1):E5. PubMed ID: 16029971
[TBL] [Abstract][Full Text] [Related]
22. Bleeding complications in patients with hematologic malignancies.
Franchini M; Frattini F; Crestani S; Bonfanti C
Semin Thromb Hemost; 2013 Feb; 39(1):94-100. PubMed ID: 23247655
[TBL] [Abstract][Full Text] [Related]
23. Thrombotic problems in hematologic malignancies.
Falanga A
Rev Clin Exp Hematol; 2004 Jun; 8(1):1 p preceding E1. PubMed ID: 16874948
[No Abstract] [Full Text] [Related]
24. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients.
Bergqvist D
Dis Colon Rectum; 2006 Oct; 49(10):1620-8. PubMed ID: 17019655
[TBL] [Abstract][Full Text] [Related]
25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated thrombosis.
Sood SL
Curr Opin Hematol; 2009 Sep; 16(5):378-85. PubMed ID: 19606029
[TBL] [Abstract][Full Text] [Related]
27. Pathogenesis of thrombotic disorders in patients with cancer.
Sallah S; Ahmad O; Kaiser HE
In Vivo; 2000; 14(1):251-3. PubMed ID: 10757083
[TBL] [Abstract][Full Text] [Related]
28. Cancer-associated thrombosis: risk factors, candidate biomarkers and a risk model.
Sud R; Khorana AA
Thromb Res; 2009; 123 Suppl 4():S18-21. PubMed ID: 19303497
[TBL] [Abstract][Full Text] [Related]
29. Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group.
Kitchens CS; Erkan D; Brandão LR; Hahn S; James AH; Kulkarni R; Pericak-Vance M; Vance J; Ortel TL
Am J Med; 2011 Apr; 124(4):290-6. PubMed ID: 21435416
[TBL] [Abstract][Full Text] [Related]
30. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
Jakó J; Szerafin L; Nagy P
Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
[TBL] [Abstract][Full Text] [Related]
31. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
Holzheimer RG
Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
[TBL] [Abstract][Full Text] [Related]
32. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
33. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
34. Thromboembolic risk in hematological malignancies.
Franchini M
Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
[TBL] [Abstract][Full Text] [Related]
35. Thrombosis in hematological malignancies: mechanisms and implications.
Horowitz NA; Brenner B
Thromb Res; 2020 Jul; 191 Suppl 1():S58-S62. PubMed ID: 32736780
[TBL] [Abstract][Full Text] [Related]
36. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study.
Cortelezzi A; Moia M; Falanga A; Pogliani EM; Agnelli G; Bonizzoni E; Gussoni G; Barbui T; Mannucci PM;
Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009
[TBL] [Abstract][Full Text] [Related]
37. Prevention of deep vein thrombosis in cancer patients.
Lee AY
Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
[TBL] [Abstract][Full Text] [Related]
38. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
39. Vascular liver disorders (II): portal vein thrombosis.
Hoekstra J; Janssen HL
Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
[TBL] [Abstract][Full Text] [Related]
40. Oral anticoagulants as secondary prophylaxis of thrombosis in patients with polycythemia vera: a retrospective analysis of 15 patients.
Bachleitner-Hofmann T; Grumbeck E; Gisslinger H
Thromb Res; 2003; 112(4):229-32. PubMed ID: 14987916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]